Emphasis on Nutritional Assessment of the Aging Population, Expansion of Home Healthcare Sector & Clinical Significance Shed on Nutrition for Cancer Survivors to Drive the Clinical Nutrition Products Market

The global market for Clinical Nutrition Products is projected to reach US$60.8 billion by 2025, driven by increasing geriatric and infant population, rising incidence of chronic diseases like cancer and diabetes, aging population & high risk of nutritional deficiencies, growing number of preterm births, and the shift towards home care. Technological advancements related to tube feeding, and increasing case of gut dysfunction are the other growth drivers.

The global clinical nutrition market is heading for lucrative gains owing to a number of factors, including increasing geriatric and infant population, rising incidence of chronic and lifestyle-related diseases, growing number of malnourished patients, increasing number of preterm births, and the shift towards home care. Malnutrition is one of the most common concerns among elderly people and patients suffering from chronic diseases. The constant rise in the number of geriatric people with weak digestive systems implies that chronic diseases and loss of appetite are common issues confronting this age group, thus necessitating administration of clinical nutrition solutions. Rise in malnutrition cases owing to longer hospital stays is also necessitating the use of clinical nutrition therapies. Additionally, the trend towards homecare for the sick and elderly is set to gain further momentum in the coming years, offering a case for at-home use of clinical nutrition products. The market is also benefiting from sustained investments being made by manufacturers as well as government agencies to develop innovative products.

Infant nutrition represents the largest and the fastest growing product category in the global clinical nutrition products market. The number of prematurely born babies is witnessing a steady increase across the world. The demand for safe, high quality, and nutritive products for meeting the nutritional needs of premature infants, low-weight infants, and those afflicted by certain medical conditions is thus expected to fuel growth in the infant nutrition market over the coming years. The clinical nutrition market is also likely to receive notable boost from strong growth exhibited by the enteral nutrition segment, owing to ongoing technological advances related to tubing feeds, along with increasing cases of gut dysfunction.

As stated by the new market research report on Clinical Nutrition Products, developed regions of the US and Europe continue to dominate as the largest markets for the clinical nutrition products market. The United States represents the largest market worldwide. Rising cases of malnutrition among the elderly and those suffering from chronic illnesses, increase in preterm births, high level of awareness about the benefits of clinical nutrition, and the availability of reimbursement coverage are the factors driving the market. Emerging markets have emerged as the frontiers of growth in the clinical nutrition products market. Rising life expectancies, growth in the number of disease-specific therapies, heightened awareness about benefits of clinical nutrition, changing lifestyles, and growing prominence of home-based patient care are driving demand for clinical nutrition products in emerging nations. Asia-Pacific represents the fastest growing regional market with a CAGR of 9.5% over the analysis period.

Major players in the market include Abbott Nutrition, Baxter International Inc., B. Braun Melsungen AG, Groupe Danone, Fresenius Kabi AG, Nutricia North America, ICU Medical Inc., Mead Johnson & Company LLC, Meiji Co. Ltd., Nestlé Health Science S.A, Otsuka Pharmaceutical Factory Inc., among others.

The research report titled “Clinical Nutrition Products- Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets, such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (Australia, China, India and Rest of Asia-Pacific), The Middle East & Africa, and Latin America ((Brazil, Mexico and Rest of Latin America). The market is analyzed by the following product segments - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

Comments

Popular posts from this blog

The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The Global Market for Private Tutoring Services is Forecast to Reach US$227 Billion by 2022